Reacting to a media report quoting a study done in London which said herbal medicines containing toxic aristolochic acid used for slimming and to treat ashthma and arthritis, are exposing people to kidney failure risks, the ADMA said the scientific research should mention the dose and duration of aristolochic use.
The ADMA, in a letter to the Secretary of Ministry of Health and Family Welfare, says aristolochia indica is one of the two plants in ancient literature which are known to possess aristolochic acid and aristolochia is recommended for short durations.
"Ayurvedic physicians always recommend the use of herbal medicines in their natural form and avoid the use of their active constituents in the extracted form", it added.
A study from King's College London last month had claimed millions of people continue to be exposed to significant health risk due to herbal medicines containing toxic aristolochic acids widely used in China and India.
ADMA also referred to a study published in an American Journal of Medicine in 2000 which found that aritolochia with total doses of more than 200gm taken for mean duration of 15 months was associated with a higher risk of urothelial carcinoma.
"This dose is almost more than 100 times the dose recommended in Ayurvedic texts and that too for quite a long duration," the ADMA letter said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
